The path to a successful HIV vaccine depends on a critical first step—activating specific immune cells that induce broadly neutralizing antibodies. Reporting Jan. 4 in the journal Cell, a research ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

A new antibody pair neutralizes all current variants of concern of SARS-CoV-2. There is an effective need for monoclonal antibody treatments for those suffering from moderate to severe Covid-19. While ...

Standing out from the crowd illustration. Businessman thinking twice about following the crowd over a cliff. Files included – jpg, ai (version 8 and CS3), svg, and eps (version 8) While common sense ...

The potential utility of neutralizing antibodies as anti-viral treatments have led many researchers to study the humoral immune response to the severe acute respiratory syndrome coronavirus 2 ...

CAS and ACROBiosystems recently published new research in the Nature journal focussed on the COVID-19 Omicron variant. The paper is titled “Memory B cell repertoire from triple vaccines against ...

When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...